DOI: 10.1128/AAC.02015-16
Article Information
PubMed
Published By
History
- Received September 16, 2016
- Returned for modification October 6, 2016
- Accepted November 20, 2016
- Published online January 24, 2017.
Copyright & Usage
Copyright © 2017 American Society for Microbiology. All Rights Reserved.
Article Versions
- Accepted Manuscript version (November 28, 2016).
- You are viewing the most recent version of this article.
Author Information
- Evan J. Zasowskia,
- Trang D. Trinha,
- Kimberly C. Claeysa,b,
- Anthony M. Casapaoa,c,
- Noor Sabaghaa,
- Abdalhamid M. Lagnfa,
- Kenneth P. Klinkerd,
- Susan L. Davisa,e and
- Michael J. Rybaka,f,g
- aAnti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA
- bDepartment of Pharmacy Practice, University of Maryland School of Pharmacy, Baltimore, Maryland, USA
- cDepartment of Pharmacy Practice, Husson University School of Pharmacy, Bangor, Maine, USA
- dUniversity of Florida, College of Pharmacy, Gainesville, Florida, USA
- eDepartment of Pharmacy Services, Henry Ford Hospital, Detroit, Michigan, USA
- fDepartment of Medicine, Division of Infectious Diseases, School of Medicine, Wayne State University, Detroit, Michigan, USA
- gDepartment of Pharmacy Services, Detroit Medical Center, Detroit, Michigan, USA
- Address correspondence to Michael J. Rybak, M.Rybak{at}wayne.edu.
Citation Zasowski EJ, Trinh TD, Claeys KC, Casapao AM, Sabagha N, Lagnf AM, Klinker KP, Davis SL, Rybak MJ. 2017. Multicenter observational study of ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother 61:e02015-16. https://doi.org/10.1128/AAC.02015-16.
